{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:25:15Z","timestamp":1790821515943,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":55,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015153","name":"Fondation Air Liquide","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015153","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Microbial Sciences"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.crmicr.2025.100367","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T17:35:50Z","timestamp":1740764150000},"page":"100367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Assessment of the efficacy of an antimicrobial peptide in the context of cystic fibrosis airways"],"prefix":"10.1016","volume":"8","author":[{"given":"Albane","family":"Jouault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e8s","family":"Jeguirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e8s Ben Hadj","family":"Kaddour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lhousseine","family":"Touqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crmicr.2025.100367_bib0001","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-0039-1698464","article-title":"Microbiology of Cystic Fibrosis Airway Disease","volume":"40","author":"Blanchard","year":"2019","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.crmicr.2025.100367_bib0002","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0169-409X(02)00144-8","article-title":"An overview of the pathogenesis of cystic fibrosis lung disease","volume":"54","author":"Boucher","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.crmicr.2025.100367_bib0003","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12931-020-01381-5","article-title":"Cathepsin S: investigating an old player in lung disease pathogenesis, comorbidities, and potential therapeutics","volume":"21","author":"Brown","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.crmicr.2025.100367_bib0004","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1183\/09031936.00080806","article-title":"Release of the antimicrobial peptide LL-37 from DNA\/F-actin bundles in cystic fibrosis sputum","volume":"29","author":"Bucki","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.crmicr.2025.100367_bib0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/jac\/dkn176","article-title":"Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13","volume":"62","author":"Bucki","year":"2008","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1016\/j.crmicr.2025.100367_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2022.127152","article-title":"Antimicrobial peptides for tackling cystic fibrosis related bacterial infections: a review","volume":"263","author":"Bugli","year":"2022","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.crmicr.2025.100367_bib0007","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41579-022-00682-4","article-title":"Tolerance and resistance of microbial biofilms","volume":"20","author":"Ciofu","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.crmicr.2025.100367_bib0008","series-title":"Annual Data Report","year":"2021"},{"key":"10.1016\/j.crmicr.2025.100367_bib0009","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pharmthera.2017.04.002","article-title":"Antimicrobial peptides: role in human disease and potential as immunotherapies","volume":"178","author":"De la Fuente-N\u00fa\u00f1ez","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.crmicr.2025.100367_bib0010","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1039\/D0RA09739J","article-title":"Antibiofilm peptides: overcoming biofilm-related treatment failure","volume":"11","author":"Dostert","year":"2021","journal-title":"RSC. Adv."},{"key":"10.1016\/j.crmicr.2025.100367_bib0011","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1016\/j.peptides.2006.07.018","article-title":"The antimicrobial peptide cathelicidin interacts with airway mucus","volume":"27","author":"Felgentreff","year":"2006","journal-title":"Peptides."},{"key":"10.1016\/j.crmicr.2025.100367_bib0012","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12866-019-1416-8","article-title":"Cationic antimicrobial peptides: alternatives and\/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa","volume":"19","author":"Geitani","year":"2019","journal-title":"BMC. Microbiol."},{"key":"10.1016\/j.crmicr.2025.100367_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2021.104928","article-title":"Bactericidal effects and stability of LL-37 and CAMA in the presence of human lung epithelial cells","volume":"24","author":"Geitani","year":"2022","journal-title":"Microbes. Infect."},{"key":"10.1016\/j.crmicr.2025.100367_bib0014","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/ijms24010597","article-title":"Biofilm Formation by Staphylococcus aureus in the Specific Context of Cystic Fibrosis","volume":"24","author":"Jean-Pierre","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.crmicr.2025.100367_bib0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijpharm.2017.09.018","article-title":"Physicochemical properties of mucus and their impact on transmucosal drug delivery","volume":"532","author":"Leal","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.crmicr.2025.100367_bib0016","doi-asserted-by":"crossref","first-page":"e04061","DOI":"10.1128\/spectrum.04061-22","article-title":"Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections","volume":"11","author":"Lu","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.crmicr.2025.100367_bib0017","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/CMR.15.2.194-222.2002","article-title":"Lung infections associated with cystic fibrosis","volume":"15","author":"Lyczak","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.crmicr.2025.100367_bib0018","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jcf.2015.10.014","article-title":"A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: a single-center study","volume":"15","author":"Maliniak","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.crmicr.2025.100367_bib0019","doi-asserted-by":"crossref","first-page":"L25","DOI":"10.1152\/ajplung.00391.2007","article-title":"The \u0394F508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability","volume":"295","author":"Moreau-Marquis","year":"2008","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.crmicr.2025.100367_bib0020","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000512268","article-title":"Mucin secretion in cystic fibrosis: a systematic review","volume":"39","author":"Niv","year":"2021","journal-title":"Dig. Dis."},{"key":"10.1016\/j.crmicr.2025.100367_bib0021","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1038\/ncomms6105","article-title":"Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity","volume":"5","author":"Pernet","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crmicr.2025.100367_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106144","article-title":"Extracellular DNA in sputum is associated with pulmonary function and hospitalization in patients with cystic fibrosis","volume":"172","author":"Piva","year":"2020","journal-title":"Respir. Med."},{"key":"10.1016\/j.crmicr.2025.100367_bib0023","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jcf.2019.12.014","article-title":"Sputum trypsin-like protease activity relates to clinical outcome in cystic fibrosis","volume":"19","author":"Reihill","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.crmicr.2025.100367_bib0024","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00917319","article-title":"Lipid composition of sputum from patients with asthma and patients with cystic fibrosis","volume":"3","author":"Sahu","year":"1978","journal-title":"Inflammation"},{"key":"10.1016\/j.crmicr.2025.100367_bib0025","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/AAC.45.12.3437-3444.2001","article-title":"P-113d, an Antimicrobial Peptide Active againstPseudomonas aeruginosa, Retains Activity in the Presence of Sputum from Cystic Fibrosis Patients","volume":"45","author":"Sajjan","year":"2001","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.crmicr.2025.100367_bib0026","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1099\/jmm.0.45969-0","article-title":"Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung","volume":"54","author":"Sriramulu","year":"2005","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.crmicr.2025.100367_bib0027","doi-asserted-by":"crossref","first-page":"L599","DOI":"10.1152\/ajplung.00061.2005","article-title":"Anionic poly(amino acid)s dissolve F-actin and DNA bundles, enhance DNase activity, and reduce the viscosity of cystic fibrosis sputum","volume":"289","author":"Tang","year":"2005","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.crmicr.2025.100367_bib0028","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","article-title":"Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research","volume":"17","author":"Turner","year":"2019","journal-title":"Nat. Rev. Microbiol."}],"container-title":["Current Research in Microbial Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266651742500029X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266651742500029X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T02:22:52Z","timestamp":1749522172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266651742500029X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":28,"alternative-id":["S266651742500029X"],"URL":"https:\/\/doi.org\/10.1016\/j.crmicr.2025.100367","relation":{},"ISSN":["2666-5174"],"issn-type":[{"value":"2666-5174","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the efficacy of an antimicrobial peptide in the context of cystic fibrosis airways","name":"articletitle","label":"Article Title"},{"value":"Current Research in Microbial Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crmicr.2025.100367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100367"}}